Sign In
Buy OGN
$13.40
+0.0200 (+0.149%)
At Close: Jun 03, 2026
Organon & Co. (OGN) To Go Ex-Dividend on November 19th
12:14pm, Sunday, 14'th Nov 2021 Transcript Daily
Organon & Co. (NYSE:OGN) declared a quarterly dividend on Friday, November 12th, Wall Street Journal reports. Investors of record on Monday, November 22nd will be given a dividend of 0.28 per share on Thursday, December 16th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 3.32%. The ex-dividend date of []
Organon: Post Earnings Dip Is A Buy Opportunity Based On Jaw-Dropping Fundamentals
07:38pm, Friday, 12'th Nov 2021
Organon was formed via the spin-out of Merck's Women's Health, Biosimilars and Established Brands divisions - shares began trading in May. On Nov. 11, the company reported Q321 earnings, affirming FY2
Organon & Co. (OGN) CEO Kevin Ali on Q3 2021 Earnings Conference Call - Earnings Call Transcript
01:43pm, Thursday, 11'th Nov 2021
Organon & Co. (OGN) CEO Kevin Ali on Q3 2021 Earnings Conference Call - Earnings Call Transcript
Organon's (OGN) Earnings & Revenues Surpass Estimates in Q3
12:59pm, Thursday, 11'th Nov 2021
Organon's (OGN) earnings and revenues trump estimates in the third quarter of 2021. Shares down in pre-market trading.
Organon's stock slides after announcing deal with Forendo Pharma
11:42am, Thursday, 11'th Nov 2021
Shares of Organon & Co. OGN, -6.36% were down 6.7% in trading on Thursday after the company said it plans to acquire Forendo Pharma, a privately held company developing an endometriosis therapy. As pa
Organon (OGN) to Report Q3 Earnings: What's in the Cards?
01:03pm, Monday, 08'th Nov 2021
Organon (OGN) is set to provide updates on its earnings and revenues when it reports third-quarter 2021 results.
Here's Why Warren Buffett Isn't Buying Many Stocks Right Now
05:52am, Sunday, 17'th Oct 2021
And why you might want to copy the legendary investor's cautious approach.
3 Buyable Dogs Bolster Buffett's October Dividend Holdings
04:03pm, Friday, 15'th Oct 2021
This Buffett holdings list from Kiplinger first appeared 8/17/21 online. YCharts and Dogs of The Dow also track this Buffett/Berkshire Batch. Here is your update from 10/13/21 YCharts data.
Organon Launches New Fertility Journey Website as Part of Ongoing Commitment to Help Address the Needs of Women
06:50am, Friday, 15'th Oct 2021
JERSEY CITY, N.J.--(BUSINESS WIRE)-- #Health--Organon (NYSE: OGN) today announced the launch of a new website – Fertility Journey – that helps inform and empower people with resources and informat
Organon Is Merck's Spin-Off And Your New Dividend Prospect
08:36am, Saturday, 25'th Sep 2021
Organon is a new company listed on June after the spin-off from Merck. Spin-off companies tend to outperform the broad market.
Build Your Dividend Factory: 2 Irresistible Bargains
02:09am, Wednesday, 22'nd Sep 2021
Dislocations between price and value remind me that it's a market for stocks rather than the stock market. I highlight 2 names that are trading in deep value territory and are set up for potentially s
Organon Aims to Ignite Worldwide Conversation Around Unplanned Pregnancy
12:01am, Tuesday, 21'st Sep 2021
JERSEY CITY, N.J.--(BUSINESS WIRE)-- #Health--Organon issues Public Service Announcement inviting women to ignite a global conversation on unplanned pregnancy.
3 Ideal Dogs Brighten Buffett's 29 September Dividend Holdings
11:53am, Saturday, 18'th Sep 2021
3 Ideal Dogs Brighten Buffett's 29 September Dividend Holdings
Organon Is An Irresistible Bargain, Here's Why
10:33pm, Monday, 06'th Sep 2021
Organon Is An Irresistible Bargain, Here's Why
3 Reasons To Buy Organon Stock, Says BofA Analyst
11:01am, Wednesday, 01'st Sep 2021
Organon & Co (NYSE:OGN), which has recently spun-off from Merck & Co., Inc. (NYSE:MRK), has “inherited a global business across three segments,” namely Women's Health, Legacy and Biosimilars brand
